Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controlsDavid G. Standaert, Chelsea Caspell‐Garcia, Christopher S. Coffey et al.|Neurology|2017Cited by 152
Safety and Tolerability of SRX246, a Vasopressin 1a Antagonist, in Irritable Huntington’s Disease Patients—A Randomized Phase 2 Clinical TrialMichael Brownstein, Stephanie Lowenhaupt, Jon Yankey et al.|Journal of Clinical Medicine|2020Cited by 32